Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 150 of 305 entries
View as:

Intervention Effect of TP and AOB-w on Acrylamide Exposure in Chinese Adolescents

Phase: N/A Priority: Normal
NCT ID: NCT03118167 Org: User:
Start: 05/31/14 End: 12/31/14 Due: 12/31/15

Safety and Efficacy Clinical Study of Severe Hemophilia B Treatment With KL001

Phase: N/A Priority: Normal
NCT ID: NCT06119659 Org: User:
Start: 11/20/23 End: 07/10/25 Due: 07/10/26

CD19-BAFF CAR-T Cells Therapy for Patients With Autoimmune Diseases

Phase: N/A Priority: Normal
NCT ID: NCT06279923 Org: User:
Start: 04/15/24 End: 02/01/27 Due: 02/01/28

The IIT Study of Evaluation of P-IL-2 Single Agent and With Anti-PD-1

Phase: N/A Priority: Normal
NCT ID: NCT05829057 Org: User:
Start: 05/23/23 End: 06/21/25 Due: 06/21/26

Universal Dual-target NKG2D-NKp44 CAR-T Cells in Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT05976906 Org: User:
Start: 05/23/23 End: 09/30/25 Due: 09/30/26

Effect of the Intensity of Continuous Renal Replacement Therapy

Phase: N/A Priority: Normal
NCT ID: NCT01251081 Org: User:
Start: 01/31/04 End: 06/30/10 Due: 06/30/11

A Clinical Cohort Study on the Pathogen Spectrum of Hepatic Virus-caused Cirrhosis Complicated With Infection

Phase: N/A Priority: Normal
NCT ID: NCT06279845 Org: User:
Start: 03/31/24 End: 11/30/26 Due: 11/30/27

Association of Egg and Dietary Cholesterol Consumption With Mortality and Diseases

Phase: N/A Priority: Normal
NCT ID: NCT04104308 Org: User:
Start: 01/01/91 End: 12/31/15 Due: 12/31/16

18F-FAPI PET Imaging in Pancreatic Adenocarcinoma

Phase: N/A Priority: Normal
NCT ID: NCT05884463 Org: User:
Start: 04/01/21 End: 02/28/23 Due: 02/28/24

IL3 CAR-T Cell Therapy for Patients With CD123 Positive Relapsed and/or Refractory Acute Myeloid Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT04599543 Org: User:
Start: 11/15/20 End: 11/15/26 Due: 11/15/27

Saturated Fatty Acids Intake and Mortality, Diabetes, Hypertension and Overweight

Phase: N/A Priority: Normal
NCT ID: NCT03281512 Org: User:
Start: 01/01/89 End: 12/31/12 Due: 12/31/13

Split or Whole Liver Transplantation? A Multicenter Retrospective Cohort Study of Patients With Benign and Malignant Liver Disease

Phase: N/A Priority: Normal
NCT ID: NCT06359496 Org: User:
Start: 02/23/24 End: 04/02/24 Due: 04/02/25

Low-dose Aspirin Therapy for Esophageal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02326779 Org: User:
Start: 03/31/16 End: 12/31/18 Due: 12/31/19

A Study of CS1-targeted CAR-T Cells Therapy for Relapsed Multiple Myeloma After BCMA CAR-T Cells Therapy

Phase: N/A Priority: Normal
NCT ID: NCT04541368 Org: User:
Start: 12/31/20 End: 12/31/26 Due: 12/31/27

Serplulimab Combined with CAPEOX + Celecoxib As Neoadjuvant Treatment for Locally Advanced Rectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05731726 Org: User:
Start: 02/22/23 End: 12/30/25 Due: 12/30/26

Neoadjuvant Chemotherapy of Nanoparticle Albumin-bound Paclitaxel in Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02016209 Org: User:
Start: 01/31/14 End: 03/31/16 Due: 03/31/17

Laparoscopic IIeocecus-Sparing Right Hemicolectomy for Cancer of the Hepatic Flexure and Proximal Transverse Colon

Phase: N/A Priority: Normal
NCT ID: NCT04479111 Org: User:
Start: 01/01/20 End: 01/01/23 Due: 01/01/24

CD19-BAFF CAR-T Cells Therapy for Patients With Relapsed / Refractory B-cell ALL and B-cell NHL

Phase: N/A Priority: Normal
NCT ID: NCT06346912 Org: User:
Start: 05/30/24 End: 05/30/27 Due: 05/30/28

Rh-Endostatin in Combination With Icotinib for Advanced NSCLC With EGFR Mutations

Phase: N/A Priority: Normal
NCT ID: NCT02375022 Org: User:
Start: 03/31/15 End: 03/31/16 Due: 03/31/17

TAS-102 and Anlotinib in ≥3 Lines mGC

Phase: N/A Priority: Normal
NCT ID: NCT05029102 Org: User:
Start: 09/01/21 End: 12/31/24 Due: 12/31/25

MESO-CAR T Cells Therapy for Relapsed and Refractory Ovarian Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03799913 Org: User:
Start: 04/10/19 End: 04/30/22 Due: 04/30/23

Prospective Study on the Efficacy and Safety of 2 Week or 3 Week Xelox Regimen for Adjuvant Chemotherapy in CRC

Phase: N/A Priority: Normal
NCT ID: NCT03564912 Org: User:
Start: 08/12/18 End: 08/24/21 Due: 08/24/22

Sequential CD19 and CD22 CAR-T Therapy for Newly Diagnosed Ph- B-ALL

Phase: N/A Priority: Normal
NCT ID: NCT04740203 Org: User:
Start: 01/31/21 End: 01/31/25 Due: 01/31/26

Low-dose Chidamide Maintenance Therapy After Allo-HSCT for T-cell Acute Lymphoblastic Leukemia or T-cell Lymphomas

Phase: N/A Priority: Normal
NCT ID: NCT05991973 Org: User:
Start: 07/15/23 End: 07/31/27 Due: 07/31/28

An Exploratory Clinical Study Evaluating the Safety and Efficacy of Anti CD30 CAR T Cells in Patients With CD30+ Relapsed/Refractory Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT05208853 Org: User:
Start: 02/10/22 End: 02/10/22 Due: 02/10/23